Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Rationale for the advancement of PI3K pathway inhibitors for personalized chordoma therapy.

Michmerhuizen NL, Owen JH, Heft Neal ME, Mann JE, Leonard E, Wang J, Zhai J, Jiang H, McHugh JB, Brenner JC, Prince MEP.

J Neurooncol. 2020 Feb 17. doi: 10.1007/s11060-020-03418-7. [Epub ahead of print]

PMID:
32067197
2.

Speech and swallowing outcomes after laryngectomy for the dysfunctional irradiated larynx.

Farlow JL, Birkeland AC, Hardenbergh A, Lyden T, Brenner JC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Rosko AJ, Spector ME.

Eur Arch Otorhinolaryngol. 2020 Jan 27. doi: 10.1007/s00405-020-05809-y. [Epub ahead of print]

PMID:
31989269
3.

Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.

Beeler WH, Bellile EL, Casper KA, Jaworski E, Burger NJ, Malloy KM, Spector ME, Shuman AG, Rosko A, Stucken CL, Chinn SB, Dragovic AF, Chapman CH, Owen D, Jolly S, Bradford CR, Prince MEP, Worden FP, Jagsi R, Mierzwa ML, Swiecicki PL.

Oral Oncol. 2020 Feb;101:104521. doi: 10.1016/j.oraloncology.2019.104521. Epub 2019 Dec 23.

PMID:
31877502
4.

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.

Luo X, Donnelly CR, Gong W, Heath BR, Hao Y, Donnelly LA, Moghbeli T, Tan YS, Lin X, Bellile E, Kansy BA, Carey TE, Brenner JC, Cheng L, Polverini PJ, Morgan MA, Wen H, Prince ME, Ferris RL, Xie Y, Young S, Wolf GT, Chen Q, Lei YL.

J Clin Invest. 2020 Feb 24. pii: 129497. doi: 10.1172/JCI129497. [Epub ahead of print]

5.

Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy.

Heft Neal ME, Brennan J, Brenner JC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, McLean SA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Rosko AJ, Spector ME.

Ann Surg Oncol. 2020 Feb;27(2):451-457. doi: 10.1245/s10434-019-07841-7. Epub 2019 Sep 19.

PMID:
31538289
6.

Paediatric hearing loss: a community-based survey in peri-urban Kumasi, Ghana.

Larsen-Reindorf R, Otupiri E, Anomah JE, Edwards BM, Frimpong B, Waller B, Prince ME, Basura GJ.

J Laryngol Otol. 2019 Aug 22:1-9. doi: 10.1017/S0022215119001658. [Epub ahead of print]

PMID:
31434583
7.

Wire bristle foreign body: Never in the same place twice.

Prince AD, Bauer AM, Xie Y, Prince ME.

SAGE Open Med Case Rep. 2019 May 29;7:2050313X19853443. doi: 10.1177/2050313X19853443. eCollection 2019.

8.

Assessment of Intraoperative Nerve Monitoring Parameters Associated With Facial Nerve Outcome in Parotidectomy for Benign Disease.

Haring CT, Ellsperman SE, Edwards BM, Kileny P, Kovatch D, Mannarelli GR, Meloch MA, Miller C, Pitts C, Prince MEP, Bradford CR, Wolf GT, Casper KA, Malloy KM, Chinn SB, Shuman AG, McKean EL, VanKoevering KK, Stucken CL, McLean SA, Marentette LJ, Rosko AJ, Spector ME.

JAMA Otolaryngol Head Neck Surg. 2019 May 2. doi: 10.1001/jamaoto.2019.1041. [Epub ahead of print]

PMID:
31045218
9.

Integrated Otolaryngology-Anesthesiology Clinical Skills and Simulation Rotation: A Novel 1-Month Intern Curriculum.

Kovatch KJ, Harvey RS, Schechtman SA, Healy DW, Malloy KM, Prince MEP, Thorne MC.

Ann Otol Rhinol Laryngol. 2019 Aug;128(8):715-720. doi: 10.1177/0003489419840682. Epub 2019 Apr 2.

PMID:
30938180
10.

Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.

Farlow JL, Birkeland AC, Rosko AJ, VanKoevering K, Haring CT, Smith JD, Brenner JC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, McLean SA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME.

Ann Surg Oncol. 2019 Aug;26(8):2542-2548. doi: 10.1245/s10434-019-07270-6. Epub 2019 Mar 4.

PMID:
30830535
11.

Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy.

Hoesli R, Brennan JR, Rosko AJ, Birkeland AC, Malloy KM, Moyer JS, Prince MEP, Shuman AG, Chinn SB, Stucken CL, Casper KA, Spector ME.

Ann Surg Oncol. 2019 May;26(5):1320-1325. doi: 10.1245/s10434-019-07262-6. Epub 2019 Feb 25.

PMID:
30805812
12.

Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.

Hawkins PG, Mierzwa ML, Bellile E, Jackson WC, Malloy KM, Chinn SB, Spector ME, Shuman AG, Stucken CL, McLean SA, Bradford CR, Prince ME, Carey TE, Worden FP, Swiecicki PL, Taylor JMG, Wolf GT, Eisbruch A, Casper KA.

Head Neck. 2019 Apr;41(4):857-864. doi: 10.1002/hed.25336. Epub 2019 Feb 18.

PMID:
30775826
13.

Correction: Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.

Owusu-Afriyie O, Owiredu WKBA, Owusu-Danquah K, Komarck C, Foltin SK, Larsen-Reindorf R, Acheampong E, Quayson SE, Prince ME, McHugh JB, Donkor P, Merajver SD, Brenner JC.

PLoS One. 2018 Dec 19;13(12):e0209696. doi: 10.1371/journal.pone.0209696. eCollection 2018.

14.

Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.

Smith JD, Birkeland AC, Rosko AJ, Hoesli RC, Foltin SK, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Wolf GT, Bradford CR, Prince ME, Brenner JC, Spector ME.

Head Neck. 2019 Feb;41(2):423-428. doi: 10.1002/hed.25444. Epub 2018 Dec 12.

15.

Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.

Cheng H, Yang X, Si H, Saleh AD, Xiao W, Coupar J, Gollin SM, Ferris RL, Issaeva N, Yarbrough WG, Prince ME, Carey TE, Van Waes C, Chen Z.

Cell Rep. 2018 Oct 30;25(5):1332-1345.e5. doi: 10.1016/j.celrep.2018.10.007.

16.

Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.

Mann JE, Smith JD, Birkeland AC, Bellile E, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Moyer JS, Wolf GT, Bradford CR, Prince ME, Carey TE, McHugh JB, Spector ME, Brenner JC.

Cancer Immunol Immunother. 2019 Feb;68(2):213-220. doi: 10.1007/s00262-018-2256-3. Epub 2018 Oct 25.

17.

Trends in Post-Interview Communication Practices.

Harvey RS, Kovatch KJ, Prince MEP, Malloy KM, Thorne MC.

Laryngoscope. 2019 Mar;129(3):607-612. doi: 10.1002/lary.27331. Epub 2018 Sep 24.

18.

The Spider Limb Positioner in subscapular system free flaps.

Stevens JR, Rosko AJ, Marchiano E, Haring C, Chinn SB, Malloy KM, Prince ME, Casper K, Moyer J, Chepeha D, Stucken CL, Spector ME.

Oral Oncol. 2018 Oct;85:24-28. doi: 10.1016/j.oraloncology.2018.08.004. Epub 2018 Aug 17.

PMID:
30220315
19.

Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.

Owusu-Afriyie O, Owiredu WKBA, Owusu-Danquah K, Komarck C, Foltin SK, Larsen-Reindorf R, Acheampong E, Quayson SE, Prince MEP, McHugh JB, Donkor P, Merajver SD, Brenner JC.

PLoS One. 2018 Aug 23;13(8):e0202790. doi: 10.1371/journal.pone.0202790. eCollection 2018. Erratum in: PLoS One. 2018 Dec 19;13(12):e0209696.

20.

Comparison of Outcomes in Medical Therapy vs Surgical Intervention of Esophageal Foreign Bodies.

Lin AY, Tillman BN, Thatcher AL, Graves CR, Prince ME.

Otolaryngol Head Neck Surg. 2018 Oct;159(4):656-661. doi: 10.1177/0194599818778277. Epub 2018 Jun 5.

PMID:
29865972
21.

Weighing Entrustment Decisions with Patient Care during Residency Training.

Kovatch KJ, Prince MEP, Sandhu G.

Otolaryngol Head Neck Surg. 2018 Jun;158(6):1024-1027. doi: 10.1177/0194599818764652. Epub 2018 Mar 20. No abstract available.

22.

Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.

Tan YS, Sansanaphongpricha K, Prince MEP, Sun D, Wolf GT, Lei YL.

J Dent Res. 2018 Jun;97(6):627-634. doi: 10.1177/0022034518764416. Epub 2018 Mar 13. Review.

23.

Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.

Hoesli R, Birkeland AC, Rosko AJ, Issa M, Chow KL, Michmerhuizen NL, Mann JE, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, McHugh JB, Brenner JC, Spector ME.

Oral Oncol. 2018 Feb;77:83-89. doi: 10.1016/j.oraloncology.2017.12.003. Epub 2017 Dec 23.

24.

Head and neck paragangliomas: A two-decade institutional experience and algorithm for management.

Smith JD, Harvey RN, Darr OA, Prince ME, Bradford CR, Wolf GT, Else T, Basura GJ.

Laryngoscope Investig Otolaryngol. 2017 Nov 11;2(6):380-389. doi: 10.1002/lio2.122. eCollection 2017 Dec.

25.

Hypothyroidism and Wound Healing After Salvage Laryngectomy.

Rosko AJ, Birkeland AC, Bellile E, Kovatch KJ, Miller AL, Jaffe CC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME.

Ann Surg Oncol. 2018 May;25(5):1288-1295. doi: 10.1245/s10434-017-6278-4. Epub 2017 Dec 20.

26.

Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.

Subramanian C, Kovatch KJ, Sim MW, Wang G, Prince ME, Carey TE, Davis R, Blagg BSJ, Cohen MS.

Neoplasia. 2017 Dec;19(12):1003-1011. doi: 10.1016/j.neo.2017.09.003. Epub 2017 Nov 6.

27.

National trends in otolaryngology intern curricula following Accreditation Council for Graduate Medical Education changes.

Kovatch KJ, Harvey RS, Prince MEP, Thorne MC.

Laryngoscope. 2018 Aug;128(8):1811-1816. doi: 10.1002/lary.26960. Epub 2017 Oct 9.

28.

Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.

Birkeland AC, Beesley L, Bellile E, Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME.

Head Neck. 2017 Dec;39(12):2512-2518. doi: 10.1002/hed.24918. Epub 2017 Sep 30.

29.

Capecitabine after Surgical Salvage in Recurrent Squamous Cell Carcinoma of Head and Neck.

Manohar PM, Sapir E, Bellile E, Swiecicki PL, Pearson AT, Prince ME, Shuman AG, Bradford CR, Chepeha DB, Wolf GT, Eisbruch A, Worden FP, Spector ME.

Otolaryngol Head Neck Surg. 2017 Dec;157(6):995-997. doi: 10.1177/0194599817722948. Epub 2017 Aug 15.

PMID:
28809131
30.

Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.

Gainor DL, Marchiano E, Bellile E, Spector ME, Taylor JMG, Wolf GT, Hogikyan ND, Prince ME, Bradford CR, Eisbruch A, Worden F, Shuman AG.

Otolaryngol Head Neck Surg. 2017 Oct;157(4):625-630. doi: 10.1177/0194599817711374. Epub 2017 Jun 13.

31.

Preoperative Tracheostomy Is Associated with Poor Disease-Free Survival in Recurrent Laryngeal Cancer.

Birkeland AC, Rosko AJ, Beesley L, Bellile E, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME.

Otolaryngol Head Neck Surg. 2017 Sep;157(3):432-438. doi: 10.1177/0194599817709236. Epub 2017 Jun 6.

32.

Erratum. UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.

Prince MEP, Fan X.

J Neurosurg. 2018 Mar;128(3):948. doi: 10.3171/2017.4.JNS16877a. Epub 2017 May 19. No abstract available.

PMID:
28524794
33.

Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.

Birkeland AC, Foltin SK, Michmerhuizen NL, Hoesli RC, Rosko AJ, Byrd S, Yanik M, Nor JE, Bradford CR, Prince ME, Carey TE, McHugh JB, Spector ME, Brenner JC.

Oral Oncol. 2017 May;68:5-8. doi: 10.1016/j.oraloncology.2017.02.025. Epub 2017 Mar 10.

34.

UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.

Owen JH, Komarck CM, Wang AC, Abuzeid WM, Keep RF, McKean EL, Sullivan S, Fan X, Prince MEP.

J Neurosurg. 2018 Mar;128(3):701-709. doi: 10.3171/2016.10.JNS16877. Epub 2017 Apr 21. Erratum in: J Neurosurg. 2018 Mar;128(3):948.

35.

Survival and Margin Status in Head and Neck Radiation-Induced Sarcomas and De Novo Sarcomas.

Rosko AJ, Birkeland AC, Chinn SB, Shuman AG, Prince ME, Patel RM, McHugh JB, Spector ME.

Otolaryngol Head Neck Surg. 2017 Aug;157(2):252-259. doi: 10.1177/0194599817700389. Epub 2017 Apr 11.

PMID:
28397585
36.

Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.

Walline HM, Goudsmit CM, McHugh JB, Tang AL, Owen JH, Teh BT, McKean E, Glover TW, Graham MP, Prince ME, Chepeha DB, Chinn SB, Ferris RL, Gollin SM, Hoffmann TK, Bier H, Brakenhoff R, Bradford CR, Carey TE; University of Michigan Head and Neck Specialized Program of Research Excellence (SPORE) Program.

Head Neck. 2017 May;39(5):840-852. doi: 10.1002/hed.24729. Epub 2017 Feb 25.

37.

Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.

Wolf GT, Bellile E, Eisbruch A, Urba S, Bradford CR, Peterson L, Prince ME, Teknos TN, Chepeha DB, Hogikyan ND, McLean SA, Moyer J, Taylor JMG, Worden FP.

JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):355-366. doi: 10.1001/jamaoto.2016.3669.

38.

E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.

Spector ME, Sacco AG, Bellile E, Taylor JMG, Jones T, Sun K, Brown WC, Birkeland AC, Bradford CR, Wolf GT, Prince ME, Moyer JS, Malloy K, Swiecicki P, Eisbruch A, McHugh JB, Chepeha DB, Rozek L, Worden FP.

Clin Cancer Res. 2017 Jun 1;23(11):2723-2729. doi: 10.1158/1078-0432.CCR-16-1617. Epub 2016 Nov 21.

39.

STAT3 Inhibition as a Therapeutic Strategy for Chordoma.

Wang AC, Owen JH, Abuzeid WM, Hervey-Jumper SL, He X, Gurrea M, Lin M, Altshuler DB, Keep RF, Prince ME, Carey TE, Fan X, McKean EL, Sullivan SE.

J Neurol Surg B Skull Base. 2016 Dec;77(6):510-520. Epub 2016 May 31.

40.

Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.

Lei Y, Xie Y, Tan YS, Prince ME, Moyer JS, Nör J, Wolf GT.

Oral Oncol. 2016 Oct;61:159-65. doi: 10.1016/j.oraloncology.2016.08.003. Epub 2016 Aug 21. Review.

41.

Predictors of severe long-term toxicity after re-irradiation for head and neck cancer.

Lee JY, Suresh K, Nguyen R, Sapir E, Dow JS, Arnould GS, Worden FP, Spector ME, Prince ME, McLean SA, Shuman AG, Malloy KM, Casper K, Bradford CR, Schipper MJ, Eisbruch A.

Oral Oncol. 2016 Sep;60:32-40. doi: 10.1016/j.oraloncology.2016.06.017. Epub 2016 Jul 5.

PMID:
27531870
42.

Skin cancer of the head and neck with gross or microscopic perineural involvement: Patterns of failure.

Sapir E, Tolpadi A, McHugh J, Samuels SE, Elalfy E, Spector M, Shuman AG, Malloy KM, Prince ME, Bradford CR, Worden FP, Schipper M, Eisbruch A.

Radiother Oncol. 2016 Jul;120(1):81-6. doi: 10.1016/j.radonc.2016.06.011. Epub 2016 Jul 27.

PMID:
27475277
43.

Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.

Prince MEP, Zhou L, Moyer JS, Tao H, Lu L, Owen J, Etigen M, Zheng F, Chang AE, Xia J, Wolf G, Wicha MS, Huang S, Ren X, Li Q.

Oral Oncol. 2016 Aug;59:30-42. doi: 10.1016/j.oraloncology.2016.05.013.

44.

Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma.

Walline HM, Komarck CM, McHugh JB, Bellile EL, Brenner JC, Prince ME, McKean EL, Chepeha DB, Wolf GT, Worden FP, Bradford CR, Carey TE.

Mol Cancer Res. 2016 Oct;14(10):941-952. Epub 2016 Jul 15.

45.

Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.

Scheel A, Bellile E, McHugh JB, Walline HM, Prince ME, Urba S, Wolf GT, Eisbruch A, Worden F, Carey TE, Bradford C.

Laryngoscope. 2016 Sep;126(9):E292-9. doi: 10.1002/lary.25915. Epub 2016 Jun 27.

46.

Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.

Hu Y, Lu L, Xia Y, Chen X, Chang AE, Hollingsworth RE, Hurt E, Owen J, Moyer JS, Prince ME, Dai F, Bao Y, Wang Y, Whitfield J, Xia JC, Huang S, Wicha MS, Li Q.

Cancer Res. 2016 Aug 15;76(16):4661-72. doi: 10.1158/0008-5472.CAN-15-2664. Epub 2016 Jun 20.

47.

IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.

Finkel KA, Warner KA, Kerk S, Bradford CR, McLean SA, Prince ME, Zhong H, Hurt EM, Hollingsworth RE, Wicha MS, Tice DA, Nör JE.

Neoplasia. 2016 May;18(5):273-281. doi: 10.1016/j.neo.2016.03.004. Epub 2016 Apr 15.

48.

In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.

Rudy SF, Brenner JC, Harris JL, Liu J, Che J, Scott MV, Owen JH, Komarck CM, Graham MP, Bellile EL, Bradford CR, Prince ME, Carey TE.

J Otolaryngol Head Neck Surg. 2016 Apr 26;45:26. doi: 10.1186/s40463-016-0140-8.

49.

Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.

Zhang Y, Koneva LA, Virani S, Arthur AE, Virani A, Hall PB, Warden CD, Carey TE, Chepeha DB, Prince ME, McHugh JB, Wolf GT, Rozek LS, Sartor MA.

Clin Cancer Res. 2016 Sep 15;22(18):4735-45. doi: 10.1158/1078-0432.CCR-16-0323. Epub 2016 Apr 18.

50.

Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer.

Rosko AJ, Spector ME, Griffin GR, Vainshtein JM, Lee J, Bradford CR, Prince ME, Moyer JS, Worden FP, Eisbruch A, Chepeha DB.

Head Neck. 2016 Aug;38(8):1187-93. doi: 10.1002/hed.24348. Epub 2016 Apr 15.

Supplemental Content

Loading ...
Support Center